Literature DB >> 7570909

Collection and transfusion of blood and blood components in the United States, 1992.

E L Wallace1, W H Churchill, D M Surgenor, J An, G Cho, S McGurk, L Murphy.   

Abstract

BACKGROUND: Studies were conducted to measure the state of the United States' national blood resource in 1992 and changes therein from 1989. STUDY DESIGN AND METHODS: With data supplied by the American Red Cross and the American Association of Blood Banks, as well as data from a stratified random-sample survey of 3350 non-American Association of Blood Banks hospitals, statistical methods were applied to estimate national blood activities in 1992.
RESULTS: The total US blood supply in 1992 was 13,794,000 units, a decrease of 3.1 percent from 1989. Some 11,307,000 red cell units were transfused to 3,772,000 patients, an average of 3.0 units per transfused patient. Preoperative autologous blood deposits totaled 1,117,000 units, a 70-percent increase over 1989. Of this number, 566,000 units (50.7%) were transfused, 5,000 (4.4%) transferred to the allogeneic supply, and 546,000 (48.9%) discarded. Of 436,000 directed-donation units, 136,000 (31.2%) were transfused, 57,000 (13.1%) transferred to allogeneic supply, and 243,000 (55.7%) discarded. The total allogeneic blood supply, including imports, decreased by 7.4 percent from 1989, and allogeneic blood transfusions, including those to children, decreased by 8.6 percent. Over 8,300,000 platelet units were transfused; of these, some 3,600,000 were apheresis platelets. In addition, 2,255,000 units of plasma and 939,000 units of cryoprecipitate were transfused.
CONCLUSION: While the US blood supply was adequate for transfusion needs in 1992, blood collections and red cell transfusions had decreased substantially since 1989.

Entities:  

Mesh:

Year:  1995        PMID: 7570909     DOI: 10.1046/j.1537-2995.1995.351096026360.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  10 in total

Review 1.  Historical review: megakaryopoiesis and thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  Blood       Date:  2008-02-01       Impact factor: 22.113

Review 2.  Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agents.

Authors:  R L Basser; C G Begley
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

3.  Continued decline in blood collection and transfusion in the United States-2015.

Authors:  Katherine D Ellingson; Mathew R P Sapiano; Kathryn A Haass; Alexandra A Savinkina; Misha L Baker; Koo-Whang Chung; Richard A Henry; James J Berger; Matthew J Kuehnert; Sridhar V Basavaraju
Journal:  Transfusion       Date:  2017-06       Impact factor: 3.157

4.  Covalently immobilized glycosaminoglycans enhance megakaryocyte progenitor expansion and platelet release.

Authors:  Vipuil Kishore; James F Eliason; Howard W T Matthew
Journal:  J Biomed Mater Res A       Date:  2011-01-25       Impact factor: 4.396

5.  Use of blood components in critically ill patients in the medical intensive care unit of a tertiary care hospital.

Authors:  R N Makroo; R K Mani; Raina Vimarsh; Sudha Kansal; Kumar Pushkar; Sandeep Tyagi
Journal:  Asian J Transfus Sci       Date:  2009-07

6.  Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009.

Authors:  Alison K Klika; Travis J Small; Anas Saleh; Caleb R Szubski; Aiswarya Lekshmi Pillai Chandran Pillai; Wael K Barsoum
Journal:  J Arthroplasty       Date:  2014-06-28       Impact factor: 4.757

Review 7.  Induced pluripotent stem cell-derived human platelets: one step closer to the clinic.

Authors:  Christos Gekas; Thomas Graf
Journal:  J Exp Med       Date:  2010-12-20       Impact factor: 14.307

8.  Exogenous c-Myc Blocks Differentiation and Improves Expansion of Human Erythroblasts In vitro.

Authors:  Cristopher Geiler; Inez Andrade; Daniel Greenwald
Journal:  Int J Stem Cells       Date:  2014-11       Impact factor: 2.500

Review 9.  Infectious and immunologic consequences of blood transfusion.

Authors:  E Patchen Dellinger; Daniel A Anaya
Journal:  Crit Care       Date:  2004-06-14       Impact factor: 9.097

10.  Genetically Engineered In Vitro Erythropoiesis.

Authors:  Cristopher Geiler; Inez Andrade; Alexandra Clayton; Daniel Greenwald
Journal:  Int J Stem Cells       Date:  2016-05-30       Impact factor: 2.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.